6 Followers on Owler
OverviewCompetitorsNews & Insights

d3 Medicine Competitors or Alternatives

d3 Medicine's top competitors include Enteris BioPharma, Rani Therapeutics and PhaseBio.

Unlock 13 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

d3 Medicine's company profile

Craig Rayner

CEO

69/100
25 - 100
$0
$100K - 5M
  • $0
    $100K - 5M
  • 25 - 100
    $0
  • $100K - 5M
  • 69/100
  • 25 - 100
  • $0
  • $100K - 5M
View ProfileView
1
d3 Medicine's Competitor - Enteris BioPharma logo

Rajiv Khosla

President & CEO

90/100
25 - 100
- -
$5M - 25M
  • - -
    $5M - 25M
  • 25 - 100
    - -
  • $5M - 25M
  • 90/100
  • 25 - 100
  • - -
  • $5M - 25M
View ProfileView
2
d3 Medicine's Competitor - Rani Therapeutics logo

Talat Imran

CEO

84/100
110
$317.7M
$3.2M
  • $317.7M
    $3.2M
  • 110
    $317.7M
  • $3.2M
  • 84/100
  • 110
  • $317.7M
  • $3.2M
View ProfileView
3
d3 Medicine's Competitor - PhaseBio logo

Jonathan Mow

CEO

88/100
60
$204.1M
$11M
  • $204.1M
    $11M
  • 60
    $204.1M
  • $11M
  • 88/100
  • 60
  • $204.1M
  • $11M
View ProfileView
4
d3 Medicine's Competitor - Acer logo

Chris Schelling

Founder & CEO

88/100
25 - 100
$96.6M
$100K - 5M
  • $96.6M
    $100K - 5M
  • 25 - 100
    $96.6M
  • $100K - 5M
  • 88/100
  • 25 - 100
  • $96.6M
  • $100K - 5M
View ProfileView
5
d3 Medicine's Competitor - Cognition Therapeutics logo

Lisa Ricciardi

President & CEO

85/100
20
$299.5M
  • $299.5M
  • 20
    $299.5M
  • 85/100
  • 20
  • $299.5M
View ProfileView
d3 Medicine's top 16 competitors are Enteris BioPharma, Rani Therapeutics, PhaseBio, Antag Therapeutics, Acer, Cognition Therapeutics, Altimmune, Protagonist, Oramed, Ra Pharma, Amicus Therapeutics, Trusted Tablets, Critical Pharmaceuticals, PanOptica, Emisphere and Agilis Biotherapeutics. Together they have raised over 3.8B between their estimated 1.4K employees. d3 Medicine's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 51.4M. d3 Medicine has 33 employees and is ranked 12th among it's top 10 competitors. The top 10 competitors average 81.

d3 Medicine VS Enteris BioPharma

Enteris BioPharma is d3 Medicine's #1 competitor. Enteris BioPharma was founded in Boonton, New Jersey} in 2013. Like d3 Medicine, Enteris BioPharma also competes in the Biotechnology industry. Compared to d3 Medicine, Enteris BioPharma generates $10.3M more revenue.

d3 Medicine VS Rani Therapeutics

Rani Therapeutics is one of d3 Medicine's top competitors. Rani Therapeutics was founded in 2012 in San Jose, California. Like d3 Medicine, Rani Therapeutics also operates in the Biotechnology industry. Rani Therapeutics generates $2M more revenue than d3 Medicine.

d3 Medicine VS PhaseBio

PhaseBio is a top competitor of d3 Medicine. PhaseBio was founded in 2002, and is headquartered in Malvern, Pennsylvania. Like d3 Medicine, PhaseBio also competes in the Biotechnology field. PhaseBio generates $9.8M more revenue vs. d3 Medicine.

Looking for similar companies to d3 Medicine?

Similar Companies

Biotechnology companies in Parsippany

See 11 companies 
Life Sciences companies in New Jersey

See 24 companies 
Pharmaceuticals & Biotechnology companies in Parsippany

See 25 companies 
Life Sciences companies in New York Metropolitan Area

See 37 companies 
Companies in Parsippany with revenue in $100K-5.0M range

See 178 companies 
Life Sciences companies with revenue in $100K-5.0M range

See 204 companies 
Life Sciences companies with employees in 25-100 range

See 279 companies 
Companies in Parsippany with employees in 25-100 range

See 382 companies 
Life Sciences companies in USA

See 402 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for d3 Medicine and d3 Medicine's Competitors

June 8, 2026Zacks
Altimmune's dual-agonist pemvidutide faces key 2026 tests in MASH and alcohol-related diseases that could validate its multi-pathway liver strategy....
June 8, 2026Zacks
ALT faces a catalyst-packed 2026, with a pivotal MASH study launch and alcohol-use-disorder data set to test pemvidutide's multi-indication story....
June 8, 2026Zacks
Altimmune is betting on pemvidutide across MASH and alcohol-related liver diseases, with key 2026 data and a planned Phase III launch shaping its path....

Frequently Asked Questions about d3 Medicine

  1. Who are d3 Medicine's top competitors?

    d3 Medicine's top 3 competitors are Enteris BioPharma, Rani Therapeutics, PhaseBio.

  2. Who is similar to d3 Medicine?

    Enteris BioPharma is the most similar to d3 Medicine. Rani Therapeutics and PhaseBio are also similar to d3 Medicine.

  1. Are d3 Medicine and Enteris BioPharma competitors?

    Yes, Enteris BioPharma is one of d3 Medicine’s top competitors.